Logo

Invivoscribe Announces FDA Approval for Distribution of the Le...

SAN DIEGO, May 19, 2020 /PRNewswire-AsiaNet/ -- Invivoscribe to offer the LeukoStrat(R) CDx FLT3 Mutation Assay as an FDA approved kit with analysis software.Logo - https://mma.prnewswire.com/media/1019746/Invivoscribe_Logo.jpg In 2017, Invivoscribe's LeukoStrat(R) CDx FLT3 Mutation Ass...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660